Jiangsu Grand Xinyi Pharmaceutical Co., Ltd · 66-66 · CHINA
For Jiangsu Grand Xinyi Pharmaceutical Co., Ltd · 66-66 · CHINA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CHINA; product is Progesterone (17 alpha-hydroxy-6alpha-methylpregn-4-ene-3;20-dione); product code is 65 J - - 31 Progesterone (Progestin); date published is 11/21/2014; address is Coastal Industrial Park, Binhai County , Chen Li Road; Binhuaizhen Binhaixian , Yancheng, Jiangsu CHINA, verified against its source on 2026-09-16.
- Firm
- Jiangsu Grand Xinyi Pharmaceutical Co., Ltd verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- CHINA verified
- Address
- Coastal Industrial Park, Binhai County , Chen Li Road; Binhuaizhen Binhaixian , Yancheng, Jiangsu CHINA verified
- Date published
- 11/21/2014 verified
- Product code
- 65 J - - 31 Progesterone (Progestin) verified
- Product
- Progesterone (17 alpha-hydroxy-6alpha-methylpregn-4-ene-3;20-dione) verified
What the source says
Jiangsu Grand Xinyi Pharmaceutical Co., Ltd Date Published : 11/21/2014 Coastal Industrial Park, Binhai County , Chen Li Road; Binhuaizhen Binhaixian , Yancheng, Jiangsu CHINA 65 J - - 31 Progesterone (Progestin) Date Published: 11/21/2014 Desc: Progesterone (17 alpha-hydroxy-6alpha-methylpregn-4-ene-3;20-dione)
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.